This I think addresses your question (I hope)--also from up to date--
In the US, a booster dose is not recommended for adults with normal immune status [76]. Nevertheless, the loss of an anamnestic response and the possible loss of immunity against hepatitis B after primary vaccination as described above suggest that these individuals may be at risk of acquiring hepatitis B infection. However, the magnitude of risk has not been well defined. As an example, in a study on 493 Alaskan Natives, a protective effect of anti-HBs was demonstrated in 87 percent of individuals 22 years after vaccination [77]. Of the remaining 13 percent, none developed acute HBV.
However, there is currently only weak evidence supporting the recommendations for booster vaccination. An ongoing study will help determine the durability of HBV vaccination and provide further insight on the utility of HBV booster vaccination [78].
In high-risk individuals (eg, healthcare workers), periodic testing for anti-HBs levels and the administration of a booster vaccine, when appropriate, may be required to maintain immunity. However, more data regarding the actual risk of acquiring hepatitis B infection among individuals who completed a course of vaccination as an infant or child are needed before recommendations on booster dose administration can be formulated.
